Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This is a phase II, multicenter, double‐blind, placebo‐controlled trial to evaluate the efficacy and safety of velusetrag once a day, compared to placebo, in subjects with CIPO.
Epistemonikos ID: 49f4ea20031f2157c5d0bbf0489aca2cc5df79b3
First added on: Feb 19, 2024